France decree on untested blood donation:
This article was originally published in Clinica
The French Health Ministry has published a decree allowing exceptions to the usual requirements for testing blood for infections, namely HIV and hepatitis C, in cases of medical urgency and where the blood is for autologous use. The consent of the patient, or of a family member should be gained in the case of medical urgency prior to the use of the untested blood where no other appropriate blood in available. The decree was signed on May 3 2002.
You may also be interested in...
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.